Edwards Lifesciences (EW) Tops Q3 EPS by 2c; Guides Q4 EPS Below Views

October 28, 2013 9:01 AM

Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.68, $0.02 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found